FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

415543009: Sodium glycerophosphate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2005. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2531462014 Sodium glycerophosphate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2534991018 Sodium glycerophosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2537699013 1-(dihydrogen phosphate)-1,2,3-propanetriol sodium salt en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2537700014 Sodium 3-phosphoroglycerate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2537701013 Sodium alpha-glycerophosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2390841000005118 natriumglycerophosphat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sodium glycerophosphate (substance) Is a Sugar phosphate true Inferred relationship Some
Sodium glycerophosphate (substance) Is a Phospholipid false Inferred relationship Some
Sodium glycerophosphate (substance) Is a Replacement agent (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing sodium glycerophosphate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sodium glycerophosphate (substance) Inferred relationship Some 1
natriumglycerophosphat 4,32 g injektionsvæske, opløsning, hætteglas a 20 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sodium glycerophosphate (substance) Inferred relationship Some
Sodium glycerophosphate hydrate (substance) Is a False Sodium glycerophosphate (substance) Inferred relationship Some
Sodium glycerophosphate pentahydrate (substance) Is a False Sodium glycerophosphate (substance) Inferred relationship Some
Sodium glycerophosphate hydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Sodium glycerophosphate (substance) Inferred relationship Some
Product containing precisely sodium glycerophosphate 4.32 gram/20 milliliter conventional release solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Sodium glycerophosphate (substance) Inferred relationship Some 1
Product containing precisely sodium glycerophosphate 4.32 gram/20 milliliter conventional release solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Sodium glycerophosphate (substance) Inferred relationship Some 1
Sodium glycerophosphate pentahydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Sodium glycerophosphate (substance) Inferred relationship Some
Product containing sodium glycerophosphate in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sodium glycerophosphate (substance) Inferred relationship Some 1
Product containing only sodium glycerophosphate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sodium glycerophosphate (substance) Inferred relationship Some 1
Product containing only sodium glycerophosphate in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sodium glycerophosphate (substance) Inferred relationship Some 1
Sodium glycerophosphate 216 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium glycerophosphate (substance) Inferred relationship Some 1
Sodium glycerophosphate 216 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium glycerophosphate (substance) Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start